![Novartis plans acquisition of Advanced Accelerator Applications](https://cleanroomconnect.com/wp-content/uploads/2017/10/Advanced-Accelerator-Applications-1-1080x675.jpg)
Novartis plans acquisition of Advanced Accelerator Applications
Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender offer for 100% of the share capital of AAA subject to certain conditions. Advanced Accelerator Applications (NASDAQ:AAAP) is a radiopharmaceutical company that develops, produces and commercializes Molecular Nuclear Medicines including Lutathera®